Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2008

01-10-2008 | Melanomas

Validation of a Nomogram to Predict the Presence of Sentinel Lymph Node Metastases in Melanoma

Authors: Antonio Piñero, MD, PhD, Manuel Canteras, PhD, Eduardo Ortiz, MD, Enrique Martínez-Barba, MD, Pascual Parrilla, MD, PhD

Published in: Annals of Surgical Oncology | Issue 10/2008

Login to get access

Abstract

Background

Lymph node involvement is a very important prognostic factor for cutaneous melanoma. In this paper we try to validate a nomogram that was created at the Memorial Sloan–Kettering Cancer Center, New York, to predict the probability of metastases in the sentinel nodes of patients with cutaneous melanoma.

Methods

Values of the following variables were collected in 218 patients with cutaneous melanoma and sentinel lymph node: age, thickness, level of Clark, location of the lesion, and ulceration or not, and the nomogram was applied to assess the probability of sentinel node involvement in each patient. The discrimination of the nomogram was assessed by calculating the area under the receiver operating characteristics (ROC) curve, and to assess the accuracy of the nomogram actual probabilities were plotted against the nomogram-calculated predicted probability.

Results

The overall predictive accuracy of the nomogram was 0.869 (95% confidence interval 0.813–0.925). Mean predicted probability of sentinel node metastasis was highly correlated to the observed risk (r = 0.953; P < 0.012).

Conclusion

The nomogram is a useful diagnostic tool that provides an adequate accurate prediction of the probability of sentinel lymph node metastases in patients with cutaneous melanoma.
Literature
1.
go back to reference TNM. Malignant tumors classification. In: Sobin LH, Wittekind Ch, eds. 6th edition, New York: Wiley, 2002 TNM. Malignant tumors classification. In: Sobin LH, Wittekind Ch, eds. 6th edition, New York: Wiley, 2002
2.
go back to reference Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999;189:195–206PubMedCrossRef Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999;189:195–206PubMedCrossRef
3.
4.
go back to reference Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991;162:432–7PubMedCrossRef Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991;162:432–7PubMedCrossRef
5.
go back to reference Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Eng J Med 1977;297:627–30 Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Eng J Med 1977;297:627–30
6.
go back to reference Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clinic Proc 1986;61:697–705 Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clinic Proc 1986;61:697–705
7.
go back to reference Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255–66PubMedCrossRef Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255–66PubMedCrossRef
8.
go back to reference Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992;127:392–9PubMed Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 1992;127:392–9PubMed
9.
go back to reference Doubrovsky A, de Wilt JHW, Scolyer RA, et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2006;11:829–36CrossRef Doubrovsky A, de Wilt JHW, Scolyer RA, et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 2006;11:829–36CrossRef
10.
go back to reference Wong SL, Kattan MW, McMasters KM, et al. A nomogram that predicts the presence of sentinel lymph node metástasis in melanoma with better discrimination than the American Joint Committee on Cancer Staging System. Ann Surg Oncol 2005;12:282–8PubMedCrossRef Wong SL, Kattan MW, McMasters KM, et al. A nomogram that predicts the presence of sentinel lymph node metástasis in melanoma with better discrimination than the American Joint Committee on Cancer Staging System. Ann Surg Oncol 2005;12:282–8PubMedCrossRef
11.
go back to reference Greene KL, Meng MV, Elkin EP, et al. Validation of the Catan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol 2004;171:2255–6PubMedCrossRef Greene KL, Meng MV, Elkin EP, et al. Validation of the Catan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol 2004;171:2255–6PubMedCrossRef
12.
go back to reference Yanke BV, Gonen M, Scardino PT, et al. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 2005;173:421–4PubMedCrossRef Yanke BV, Gonen M, Scardino PT, et al. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 2005;173:421–4PubMedCrossRef
13.
go back to reference Smidt ML, Kuster DM, van der Wilt GJ, et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann Surg Oncol 2005;12:1066–72PubMedCrossRef Smidt ML, Kuster DM, van der Wilt GJ, et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann Surg Oncol 2005;12:1066–72PubMedCrossRef
14.
go back to reference Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram fro predicting nonsentinel lymph node metastases after a positive sentinel lymph node biopsy. Ann Surg Oncol 2006;13:310–20PubMedCrossRef Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram fro predicting nonsentinel lymph node metastases after a positive sentinel lymph node biopsy. Ann Surg Oncol 2006;13:310–20PubMedCrossRef
15.
go back to reference Hanley JA, Mc Neil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839–43PubMed Hanley JA, Mc Neil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839–43PubMed
16.
go back to reference Mraz-Gemhard S, Sagebiel RW, Kashani-Sabet M, et al. Prediction of sentinel node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998;134:983–7CrossRef Mraz-Gemhard S, Sagebiel RW, Kashani-Sabet M, et al. Prediction of sentinel node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998;134:983–7CrossRef
17.
go back to reference Sondak VK, Taylor JMG, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004;11:247–58PubMedCrossRef Sondak VK, Taylor JMG, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004;11:247–58PubMedCrossRef
18.
go back to reference Kesmodel SB, Karakousis CP, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanoma. Ann Surg Oncol 2005;12:449–58PubMedCrossRef Kesmodel SB, Karakousis CP, Botbyl JD, et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanoma. Ann Surg Oncol 2005;12:449–58PubMedCrossRef
19.
go back to reference Dadras SS, Lange-Asschenfeldt B, Velasco P, et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 2005;18:1232–42PubMedCrossRef Dadras SS, Lange-Asschenfeldt B, Velasco P, et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 2005;18:1232–42PubMedCrossRef
20.
go back to reference Piñero A, Martínez-Escribano J, Martínez-Barba E, et al. Are there factors that predict the result of selective sentinel lymph-node biopsy in melanoma? Rev Oncol 2004;6:283–8 Piñero A, Martínez-Escribano J, Martínez-Barba E, et al. Are there factors that predict the result of selective sentinel lymph-node biopsy in melanoma? Rev Oncol 2004;6:283–8
21.
go back to reference Leong SP, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg 2005;29:683–91PubMedCrossRef Leong SP, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma in sentinel lymph nodes and other high-risk factors based on long-term follow-up. World J Surg 2005;29:683–91PubMedCrossRef
22.
go back to reference Puleo CA, Messina JL, Riker AI, et al. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005;12:230–5PubMed Puleo CA, Messina JL, Riker AI, et al. Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005;12:230–5PubMed
23.
go back to reference Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007;109:100–8PubMedCrossRef Paek SC, Griffith KA, Johnson TM, et al. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007;109:100–8PubMedCrossRef
24.
go back to reference Mozzillo N, Caraco C, Chiofalo MG, et al. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up. Eur J Surg Oncol 2004;30:440–3PubMedCrossRef Mozzillo N, Caraco C, Chiofalo MG, et al. Sentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-up. Eur J Surg Oncol 2004;30:440–3PubMedCrossRef
Metadata
Title
Validation of a Nomogram to Predict the Presence of Sentinel Lymph Node Metastases in Melanoma
Authors
Antonio Piñero, MD, PhD
Manuel Canteras, PhD
Eduardo Ortiz, MD
Enrique Martínez-Barba, MD
Pascual Parrilla, MD, PhD
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0077-x

Other articles of this Issue 10/2008

Annals of Surgical Oncology 10/2008 Go to the issue